CEO Roberto Iacone admitted in an interview that the market remains tough, even for a biotech in the red-hot ADC world. But ...

The Paramesu Biotech IPO consists of a fresh issue of shares worth up to Rs 520 crore and an offer for sale of shares worth ...

USC professor Berislav Zlokovic is on leave after whistleblowers cast doubt on his published work and derailed trials for an experimental stroke treatment.

The Draft Red Herring Prospectus (DRHP) filed by promoter Unimark Business Solutions Private Ltd states that the proposed IPO ...

Platinum Asset Management's biotech specialist Dr Bianca Ogden outlines the major opportunities she is seeing in the sector.

Beginning with two base colors derived from fermentation, Phytolon's portfolio provides a full range of color shades, ...

A K Sood, principal scientific advisor to GoI told TOI: "I don't see any major red flag or reason to expect drastic changes .

Emerging meat alternatives – cultivated meat and precision fermentation-derived meat – need to present an appealing image to ...

Paramesu Biotech, a leading maize-based products manufacturer, files IPO papers with Sebi to raise Rs 600 crore. The IPO ...

The corporate venture capital arm of Rich Products — Rich Products Ventures (RPV) — has made an investment in Israeli biotech ...